This provider's $43.7M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 1094% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 353% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $64.14 | $24.31 | 2.64x | $39.83 | $505.4K | 20.8K | 9 |
| 2015 | $26.55 | $23.46 | 1.13x | $3.09 | $2.3M | 97.5K | 15 |
| 2016 | $63.70 | $46.95 | 1.36x | $16.75 | $2.9M | 62.5K | 8 |
| 2017 | $68.20 | $40.42 | 1.69x | $27.78 | $4.4M | 107.8K | 8 |
| 2018 | $78.98 | $50.19 | 1.57x | $28.79 | $4.3M | 86.0K | 9 |
| 2019 | $83.18 | $52.11 | 1.60x | $31.07 | $5.9M | 114.0K | 8 |
| 2020 | $84.28 | $52.99 | 1.59x | $31.29 | $6.1M | 115.0K | 10 |
| 2021 | $95.71 | $65.57 | 1.46x | $30.14 | $5.7M | 87.5K | 12 |
| 2022 | $108.72 | $77.02 | 1.41x | $31.70 | $5.5M | 70.9K | 12 |
| 2023 | $95.59 | $68.12 | 1.40x | $27.47 | $6.0M | 88.6K | 11 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 55.3K | $10.8M | $195.72 | 1.12x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 51.8K | $7.9M | $153.41 | 1.06x |
| 82542 | Chemical analysis using chromatography technique | 325.2K | $7.8M | $23.94 | 2.07x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 83.1K | $5.4M | $64.68 | 1.86x |
| 83789 | Mass spectrometry (laboratory testing method) | 168.8K | $4.0M | $23.75 | 2.14x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 13.7K | $3.2M | $231.86 | 1.27x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 8.6K | $917.8K | $106.44 | 1.09x |
| 80299 | Quantitation of therapeutic drug | 50.3K | $917.1K | $18.25 | 1.83x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 6.7K | $515.5K | $77.47 | 1.38x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 14.5K | $377.1K | $25.95 | 1.13x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.9K | $218.8K | $74.74 | 1.68x |
| G6031 | Benzodiazepines | 7.2K | $178.2K | $24.67 | 1.12x |
| G6053 | Methadone | 7.3K | $158.1K | $21.77 | 1.12x |
| G6042 | Amphetamine or methamphetamine | 7.2K | $150.2K | $20.72 | 1.12x |
| G6046 | Dihydromorphinone | 3.6K | $124.7K | $34.28 | 1.12x |
| G6045 | Dihydrocodeinone | 3.6K | $100.2K | $27.54 | 1.12x |
| G6051 | Flurazepam | 3.6K | $95.6K | $26.40 | 1.13x |
| 83925 | Opiates (drug) measurement | 3.4K | $89.7K | $26.00 | 2.63x |
| 82492 | Chemical analysis | 3.3K | $79.7K | $24.08 | 1.02x |
| G6044 | Cocaine or metabolite | 3.8K | $77.2K | $20.21 | 1.22x |
This provider submits charges 1.51 times higher than what Medicare actually pays.
A markup ratio of 1.51x means for every $100 Medicare pays, this provider initially charges $151. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data